Related Experiment Videos
Modeling cholinergic abnormalities in Down syndrome and Alzheimer's disease
D M Holtzman1, Y W Li, F H Gage
1Department of Neurology, University of California, San Francisco 94143.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies.
The journal of prevention of Alzheimer's disease·2017
Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.
Clinical pharmacology and therapeutics·2015
In vivo MRI analysis of an inflammatory injury in the developing brain.
Brain, behavior, and immunity·2009
DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.
Progress in clinical and biological research·2018
Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.
Progress in clinical and biological research·1998
The molecular basis for therapeutic concepts utilizing CD14.
Progress in clinical and biological research·1998
Endotoxin tolerance alters macrophage membrane regulatory G proteins.
Progress in clinical and biological research·1998
Molecular mechanisms responsible for endotoxin tolerance.
Progress in clinical and biological research·1998
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
Progress in clinical and biological research·1998
Design, synthesis, and preliminary antiproliferative evaluation of azetidine-functionalized pyrrolo[2,3-d]pyrimidines with integrated computational studies.
Journal of biomolecular structure & dynamics·2026
Vibrational Circular Dichroism Spectra of 2,5-Diaminoterephtalate Macrocycles Reveal Distant Vibrational Exciton Coupling.
Chemistry (Weinheim an der Bergstrasse, Germany)·2026
AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins.
Nature communications·2026